Oisin Biotechnologies
Pre-clinicalOisín Biotechnologies develops genetic medicines to address age-related diseases.
Founded
2015
Focus
Drug Delivery
About
Oisín Biotechnologies develops genetic medicines to address age-related diseases.
Funding History
2Total raised: $15.5M
Series A$12MUndisclosedFeb 15, 2020
Seed$3.5MUndisclosedJun 15, 2017
Company Info
TypePrivate
Founded2015
LocationSeattle, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile